Melanostatin (MIF-1) : central action and clinical use
Puciłowski, O.; Płaźnik, A.; Kostowski, W.
Polski Tygodnik Lekarski 38(24): 739-741
1983
ISSN/ISBN: 0032-3756 PMID: 6139794 Document Number: 211531
Document emailed within 1 workday
Related Documents
Björkman, S.; Karlsson, J.; Sievertsson, H. 1979: A comparison of central and hormal effects of peptides related to thyroliberin (TRH) and melanostatin (MIF) Acta Pharmaceutica Suecica 16(2): 95-102Ksiazek, A.; Kleinrok, Z. 1974: Central action of drugs affecting beta-adrenergic receptor. II. the central action of intraventricularly applicated propranolol in rats Polish Journal of Pharmacology and Pharmacy 26(3): 297-304
Osipova, N.A. 1994: Current principles of the clinical use of central-action analgesics Anesteziologiia i Reanimatologiia 1994(4): 16-20
Makarov, V.G.; Aleksandrova, A.E.; Shikov, A.N.; Shiler, L.V.; Ryzhenkov, V.E. 2006: Experimental and clinical study of preparation Iridol action on the central nevros system Eksperimental'naia i Klinicheskaia Farmakologiia 69(3): 23-25
van Zwieten, P.A. 1973: The central action of antihypertensive drugs, mediated via central alpha-receptors Journal of Pharmacy and Pharmacology 25(2): 89-95
Yang, X.L.; Tang, Y.H.; Zhao, X.P.; Wang, S. 1992: Central analgesic action of calcitonin and its relationship with central monoamine transmitters Zhongguo Yao Li Xue Bao 13(2): 156-158
Kabanov, V.M.; Mazurov, A.A.; Andronati, S.A. 1992: Modification of melanostatin Bioorganicheskaia Khimiia 18(8): 1013-1032
Björkman, S. 1980: Neurotropic and pituitary effects of melanostatin (MIF), thyroliberin (TRH) and structurally related peptides Acta Pharmaceutica Suecica 17(6): 352
Malec, D.; Langwiński, R. 1981: Central action of narcotic analgesics. VIII. the effect of dopaminergic stimulants on the action of analgesics in rats Polish Journal of Pharmacology and Pharmacy 33(3): 273-282
Kościelak, M.; Moniuszko-Jakoniuk, J.; Wiśniewski, K. 1980: The participation of prostaglandins in the action of kinins on the central dopaminergic system in the rat. II. Participation of PGF2 alpha in the action of kinins on the central dopaminergic system Polish Journal of Pharmacology and Pharmacy 32(3): 357-370
Kościelak, M.; Moniuszko-Jakoniuk, J.; Wiśniewski, K. 1980: The participation of prostaglandins in the action of kinins on the central dopaminergic system in the rat. III. Participation of PGE1 in the action of kinins on the central dopaminergic system Polish Journal of Pharmacology and Pharmacy 32(3): 371-394
Maj, J.; Sowińska, H.; Baran, L.; Mogilnicka, E.; Przewłocka, B. 1980: Central action of Craviten (M-71) Polish Journal of Pharmacology and Pharmacy 32(6): 823-832
Fidecka, S.; Kleinrok, Z.; Kośmider, S. 1974: The central action of four new detergents Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 29: 53-61
Jacob, H.; Spalke, G. 1971: Clinical aspects and neuropathology of central nervous system complications after acute water and electrolyte imbalance with special reference to central pontine myelinolysis Fortschritte der Neurologie Psychiatrie und Ihrer Grenzgebiete 39(4): 169-191
Zhang, S.S. 1985: The central inhibitory action of hexoprenaline Yao Xue Xue Bao 20(9): 699-701
Prandota, J. 1973: Central action of new isothiazole derivatives Archivum Immunologiae et Therapiae Experimentalis 21(2): 345-355
Jagiełło-Wójtowicz, E.; Kleinrok, Z.; Jusiak, L.; Matuszek, B.; Daniłoś, J.; Chodakowska, A. 1994: Central action of glaucine in rodents Acta Poloniae Pharmaceutica 51(2): 179-184
Monzani, A.; Di Bella, M.; Braghiroli, D.; Raffa, L.; Sandrini, M. 1982: Sulfonamides with central nervous system action. V Il Farmaco; Edizione Scientifica 37(3): 151-158
Bian, C.F.; Duan, S.M. 1981: The action of anisodine on central nervous system Yao Xue Xue Bao 16(11): 801-805
Czarnecka, E.; Pietrzak, B. 1991: The effect of doxepin on the central action of ethanol Polish Journal of Pharmacology and Pharmacy 43(6): 471-478